Kelly Kimberly A, Waterman Peter, Weissleder Ralph
Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Neoplasia. 2006 Dec;8(12):1011-8. doi: 10.1593/neo.06610.
Rapid identification of in vivo affinity ligands would have far-reaching applications for imaging specific molecular targets, in vivo systems imaging, and medical use. We have developed a high-throughput method for identifying and optimizing ligands to map and image biologic targets of interest in vivo. We directly labeled viable phage clones with far-red fluorochromes and comparatively imaged them in vivo by multichannel fluorescence ratio imaging. Using Secreted Protein Acidic and Rich in Cysteine (osteonectin) and vascular cell adhesion molecule-1 as model targets, we show that: 1) fluorescently labeled phage retains target specificity on labeling; 2) in vivo distribution can be quantitated (detection thresholds of approximately 300 phage/mm(3) tissue) throughout the entire depth of the tumor using fluorescent tomographic imaging; and 3) fluorescently labeled phage itself can serve as a replenishable molecular imaging agent. The described method should find widespread application in the rapid in vivo discovery and validation of affinity ligands and, importantly, in the use of fluorochrome-labeled phage clones as in vivo imaging agents.
快速鉴定体内亲和配体在特异性分子靶点成像、体内系统成像及医学应用方面将具有深远意义。我们已开发出一种高通量方法,用于鉴定和优化配体,以在体内绘制和成像感兴趣的生物靶点。我们用远红荧光染料直接标记有活力的噬菌体克隆,并通过多通道荧光比率成像在体内对其进行比较成像。以富含半胱氨酸的酸性分泌蛋白(骨连接蛋白)和血管细胞黏附分子-1作为模型靶点,我们发现:1)荧光标记的噬菌体在标记时保留靶点特异性;2)使用荧光断层成像可在肿瘤的整个深度定量体内分布(检测阈值约为300个噬菌体/立方毫米组织);3)荧光标记的噬菌体本身可作为可补充的分子成像剂。所述方法应在体内亲和配体的快速发现和验证中,以及重要的是在将荧光染料标记的噬菌体克隆用作体内成像剂方面得到广泛应用。